NCT03362697 (UTIPregnant) is a NA clinical trial of Probiotics in Urinary Tract Infection in Pregnancy, sponsored by Innovacion y Desarrollo de Estrategias en Salud.

Who is sponsoring NCT03362697?

NCT03362697 is sponsored by Innovacion y Desarrollo de Estrategias en Salud.

What drugs are being tested in NCT03362697?

Interventions in NCT03362697: Probiotics, Antibiotics.

What condition does NCT03362697 study?

NCT03362697 studies Urinary Tract Infection in Pregnancy.

Is NCT03362697 still recruiting?

NCT03362697 is currently completed. Last updated 20 June 2019.

Last reviewed 2019-06-20 · How we verify

NCT03362697: UTIPregnant

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lactobacillus Reuteri for Treatment of Uncomplicated UTI in Pregnant Women

Completed NA Last updated 20 June 2019

What this trial tests

NA trial testing Probiotics in Urinary Tract Infection in Pregnancy in 150 participants. Completed in 18 June 2019.

Timeline

15 December 2017

Primary endpoint
30 December 2018

18 June 2019

Quick facts

Lead sponsor	Innovacion y Desarrollo de Estrategias en Salud
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	150
Start date	15 December 2017
Primary completion	30 December 2018
Estimated completion	18 June 2019
Sites	1 location across Mexico

Drugs / interventions tested

Probiotics — full drug profile →
Antibiotics — full drug profile →

Conditions studied

Urinary Tract Infection in Pregnancy — all drugs for Urinary Tract Infection in Pregnancy →

Sponsor

Innovacion y Desarrollo de Estrategias en Salud — full company profile →

Who can join

Adults 18 to 40, female only, with Urinary Tract Infection in Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prevalence of uro-genital infections during pregnancy move between 7% to 12% in developed countries, meanwhile in developing countries this figure moved between 14% and until 55%, such is the case of Mexico. Meanwhile use of antibiotics for 3 to 7 days had established as a standard of care, the use of non-antibiotic therapy, such as cranberry powder or probiotics for prevention/treatment of this conditions is scarce. Randomized controlled trial aimed to evaluate the safety and efficacy of probiotic vs. antibiotics to treat pregnant women with uncomplicated cystitis or asymptomatic bacteriuria

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Probiotics

Trials testing the same drug.

NCT07470645 — Effects of Probiotic Supplementation on Stress and Anxiety in Students · NA · not yet recruiting
NCT06943235 — Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in th · Phase 2 · recruiting
NCT06827964 — Practice of Nutrition Package in Myanmar · NA · not yet recruiting
NCT06873165 — Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to C · NA · recruiting
NCT06583720 — Comparative Study Between Photodynamic Therapy with LED Associated with Probiotics in the Treatment of Halitosis · Phase 1 · recruiting

Other Innovacion y Desarrollo de Estrategias en Salud trials

Trials by the same sponsor.

NCT04265716 — Topical L. Reuteri in Children With Atopic Dermatitis · NA · unknown
NCT03834415 — Lactobacillus Reuteri DSM17938 in C-Section Infants · NA · completed
NCT04037826 — L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults · NA · completed
NCT03360253 — Clinical Trial of L. Reuteri in Infantile Colic 2017 · NA · unknown
NCT03377374 — L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 for the Treatment of Children With Pharyngitis and/or Tonsillitis · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03362697 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Innovacion y Desarrollo de Estrategias en Salud
Last refreshed: 20 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03362697.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing